Enavate

Enavate company information, Employees & Contact Information

Updated May 2026

Quick answer

Enavate is a IT Services and IT Consulting company and founded in 2014. It has approximately 281 employees on record. Contact data was last refreshed in May 2026. Find Enavate's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

As a leading Microsoft Gold Partner, Enavate transforms businesses and the lives they touch. To us, it's personal. Our consulting, Cloud and managed IT support services enable key decision-makers focus on their organization’s overall mission and vision, knowing that the day-to-day operations are under control. Clients in the distribution, manufacturing and professional services industries rely on our implementation expertise to improve processes, boost efficiency and stimulate agility in an ever-changing business climate. Learn more about our fresh approach to ERP, managed IT services and Cloud implementations at www.enavate.com.

Company Details

Employees
281
Founded
-
Address
1511 N West Shore Blvd, Suite 900,ukraine
Phone
+1 303 469 2346
Email
co****@****ate.com
Industry
It Services And It Consulting
NAICS
Computer Systems Design and Related Services
Other Computer Related Services
HQ
Tampa, Florida
Looking for a particular Enavate employee's phone or email?

Enavate Questions

News

Enavate Takes Over US Microsoft Dynamics Small and Medium Business from DXC Technology - MSDynamicsWorld.com

Enavate Takes Over US Microsoft Dynamics Small and Medium Business from DXC Technology MSDynamicsWorld.com

Enavate Launches AI Companion to Modernize Dynamics GP - Redmond Channel Partner

Enavate Launches AI Companion to Modernize Dynamics GP Redmond Channel Partner

Despite biotech slump, veterans of SVB and KKR launch investment firm - statnews.com

Despite biotech slump, veterans of SVB and KKR launch investment firm statnews.com

Patient Square Capital Announces the Formation of Enavate Sciences to Invest in and Support Therapeutic Companies - PR Newswire

Patient Square Capital Announces the Formation of Enavate Sciences to Invest in and Support Therapeutic Companies PR Newswire

Microsoft Gold Partner Enavate Acquires Dynamics SMB Business Unit From Columbus - - ChannelE2E

Microsoft Gold Partner Enavate Acquires Dynamics SMB Business Unit From Columbus - ChannelE2E

June 8 Quick Takes: Enavate, Venrock back Upstream’s $200M round - BioCentury

June 8 Quick Takes: Enavate, Venrock back Upstream’s $200M round BioCentury

Patient Square Capital invests $300M to support 'golden age of therapeutics' with Enavate Sciences - Fierce Biotech

Patient Square Capital invests $300M to support 'golden age of therapeutics' with Enavate Sciences Fierce Biotech

Sam Waksal’s ROCK2 biotech Graviton hauls in $35M boost from Enavate - Endpoints News

Sam Waksal’s ROCK2 biotech Graviton hauls in $35M boost from Enavate Endpoints News

ENAVATE SCIENCES GP, LLC Expands Stake in Zenas BioPharma Inc - GuruFocus

ENAVATE SCIENCES GP, LLC Expands Stake in Zenas BioPharma Inc GuruFocus

Patient Square Kickstarts Biotech Investment Firm Enavate Sciences - BioSpace

Patient Square Kickstarts Biotech Investment Firm Enavate Sciences BioSpace

Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - Business Wire

Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials Business Wire

Enavate Chief Experience Officer, Eve Cline, Honored as a 2024 Tampa Titan 100 - MSDynamicsWorld.com

Enavate Chief Experience Officer, Eve Cline, Honored as a 2024 Tampa Titan 100 MSDynamicsWorld.com

Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors - PR Newswire

Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors PR Newswire

James Boylan snags $300M to hunt for biotech deals after leaving SVB - Endpoints News

James Boylan snags $300M to hunt for biotech deals after leaving SVB Endpoints News

Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic - Business Wire

Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic Business Wire

Enavate Sciences Hires Christine Del Corsano as Chief Financial Officer - PR Newswire

Enavate Sciences Hires Christine Del Corsano as Chief Financial Officer PR Newswire

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases - Business Wire

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases Business Wire

Edd Fleming, M.D., former Senior Partner at McKinsey and Company, joins Enavate Sciences as Executive Vice President, Commercialization - PR Newswire

Edd Fleming, M.D., former Senior Partner at McKinsey and Company, joins Enavate Sciences as Executive Vice President, Commercialization PR Newswire

Top Enavate Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant